Home
Explore
Exams
Login
Get started
Home
Exam 3 reformat
Exam 3 reformat
0.0
(0)
Rate it
Studied by 0 people
Call Kai
Learn
Practice Test
Spaced Repetition
Match
Flashcards
Knowt Play
Card Sorting
1/325
There's no tags or description
Looks like no tags are added yet.
326 Terms
View all (326)
Star these 326
1
New cards
[CNS fundamentals] What does the blood-brain barrier restrict?
Passage of most highly ionized, protein-bound, and water-soluble drugs into the brain; lipid-soluble drugs generally cross more readily.
2
New cards
[CNS fundamentals] Why are neonates especially sensitive to CNS-active drugs?
Their blood-brain barrier is not fully developed, and their ability to metabolize and excrete drugs is immature.
3
New cards
[CNS fundamentals] Define drug tolerance.
A reduced response after repeated drug exposure, sometimes requiring dose adjustment to achieve the same effect.
4
New cards
[CNS fundamentals] Define physical dependence.
Physiologic adaptation that leads to withdrawal symptoms if a drug is stopped abruptly.
5
New cards
[CNS fundamentals] Are tolerance, physical dependence, and addiction interchangeable?
No. Tolerance is reduced response; physical dependence causes withdrawal on abrupt cessation; addiction involves compulsive use despite harm.
6
New cards
[CNS fundamentals] What neurotransmitter is the main inhibitory transmitter in the CNS?
GABA (gamma-aminobutyric acid); increased GABA activity generally suppresses neuronal firing.
7
New cards
[CNS fundamentals] What is the primary excitatory neurotransmitter in the CNS?
Glutamate; excessive excitation can contribute to seizures and excitotoxic neuronal injury.
8
New cards
[CNS fundamentals] Why should many CNS depressants be used cautiously together?
Their sedating effects may add together and increase fall risk, impaired consciousness, and respiratory depression.
9
New cards
[CNS fundamentals] What is the nursing priority when a patient taking a CNS depressant becomes difficult to arouse?
Assess airway, breathing, respiratory rate, oxygenation, and responsiveness before addressing less urgent effects.
10
New cards
[Parkinson disease] What neurotransmitter imbalance produces the classic motor symptoms of Parkinson disease?
Dopamine depletion in the striatum creates relative cholinergic (acetylcholine) excess.
11
New cards
[Parkinson disease] What are the major motor signs of Parkinson disease?
Resting tremor, rigidity, bradykinesia, and postural instability.
12
New cards
[Parkinson disease] Can current Parkinson medications stop neurodegeneration?
No. Drug therapy improves symptoms and function but has not been proven to stop the disease process.
13
New cards
[Parkinson disease] What are the two broad pharmacologic approaches to Parkinson disease?
Increase dopaminergic activity or reduce cholinergic activity in the brain.
14
New cards
[Carbidopa/levodopa] Why is levodopa used instead of oral dopamine for Parkinson disease?
Levodopa crosses the blood-brain barrier and converts to dopamine in the CNS; dopamine itself does not cross effectively.
15
New cards
[Carbidopa/levodopa] What is levodopa's mechanism of action?
It is a dopamine precursor converted by decarboxylase to dopamine in the brain, improving striatal dopaminergic signaling.
16
New cards
[Carbidopa/levodopa] What is carbidopa's role when combined with levodopa?
Inhibits peripheral conversion of levodopa to dopamine; more levodopa reaches the CNS and peripheral nausea may decrease.
17
New cards
[Carbidopa/levodopa] Does carbidopa itself cross the blood-brain barrier?
No. Its therapeutic role is primarily peripheral decarboxylase inhibition.
18
New cards
[Carbidopa/levodopa] Which combination is widely regarded as the most effective symptomatic treatment for Parkinson motor symptoms?
Carbidopa/levodopa (e.g., Sinemet).
19
New cards
[Carbidopa/levodopa] What does levodopa "wearing off" mean?
Parkinson symptoms return near the end of a dose interval as levodopa's effect declines.
20
New cards
[Carbidopa/levodopa] Name three strategies for levodopa wearing-off episodes.
Adjust dose timing, add a COMT or MAO-B inhibitor, or add a dopamine agonist, depending on the prescriber's plan.
21
New cards
[Carbidopa/levodopa] What are levodopa-induced dyskinesias?
Involuntary excessive movements that can develop with long-term dopaminergic therapy.
22
New cards
[Carbidopa/levodopa] What common adverse effects require monitoring with carbidopa/levodopa?
Nausea, orthostatic hypotension, dyskinesias, hallucinations/psychosis, and changes in alertness.
23
New cards
[Carbidopa/levodopa] What is a useful teaching point about high-protein meals and levodopa?
Dietary amino acids can compete with levodopa absorption/transport; consistent timing of protein intake may improve response.
24
New cards
[Carbidopa/levodopa] What harmless body-fluid change can levodopa cause?
Urine or perspiration may become darker.
25
New cards
[Dopamine agonists] Which class directly stimulates dopamine receptors without needing conversion to dopamine?
Dopamine agonists, such as pramipexole, ropinirole, and rotigotine.
26
New cards
[Dopamine agonists] Which dopamine agonists are also used for restless legs syndrome?
Pramipexole and ropinirole; rotigotine is another option.
27
New cards
[Dopamine agonists] What unusual behavioral adverse effects should be assessed with dopamine agonists?
Impulse-control problems such as compulsive gambling, shopping, eating, or hypersexuality.
28
New cards
[Dopamine agonists] What sleep-related safety issue can occur with pramipexole or ropinirole?
Severe daytime somnolence or sudden sleep attacks; avoid driving if affected.
29
New cards
[Dopamine agonists] What findings suggest a dopamine agonist is causing orthostatic hypotension?
Dizziness or lightheadedness on standing and a fall in blood pressure with position change.
30
New cards
[Dopamine agonists] What medication is available as a transdermal dopamine-agonist patch?
Rotigotine (Neupro); monitor for skin irritation and systemic dopaminergic effects.
31
New cards
[Dopamine agonists] What is apomorphine used for in advanced Parkinson disease?
Rapid, intermittent rescue of sudden hypomobility ("off") episodes; it is not an oral maintenance drug.
32
New cards
[COMT inhibitors] How do COMT inhibitors help patients taking levodopa?
They reduce peripheral levodopa breakdown, increasing its availability and prolonging benefit.
33
New cards
[COMT inhibitors] Which COMT inhibitor is often combined with carbidopa/levodopa?
Entacapone (Comtan); the fixed combination is carbidopa/levodopa/entacapone (Stalevo).
34
New cards
[COMT inhibitors] What adverse effect makes tolcapone a high-risk COMT inhibitor?
Potentially fatal hepatotoxicity; careful liver monitoring and restricted use are necessary.
35
New cards
[COMT inhibitors] What adverse effects may occur when entacapone increases levodopa exposure?
Dyskinesias, nausea, hallucinations, and orthostatic hypotension; levodopa adjustment may be needed.
36
New cards
[COMT inhibitors] What harmless urine-color change can occur with entacapone?
Yellow-orange or brownish urine discoloration.
37
New cards
[MAO-B inhibitors] How do MAO-B inhibitors help Parkinson disease?
Inhibit brain metabolism of dopamine and may extend levodopa effects.
38
New cards
[MAO-B inhibitors] Name two MAO-B inhibitors used for Parkinson disease.
Selegiline and rasagiline.
39
New cards
[MAO-B inhibitors] What potentially dangerous interaction should be assessed with MAO-B inhibitors?
Certain serotonergic drugs or meperidine can cause serious reactions, including serotonin toxicity; always screen medications.
40
New cards
[MAO-B inhibitors] What sleep complaint may occur with selegiline?
Insomnia, particularly with later dosing.
41
New cards
[Amantadine] How does amantadine help Parkinson symptoms?
Enhances dopaminergic signaling and affects glutamate pathways; can help with levodopa-induced dyskinesias.
42
New cards
[Amantadine] What adverse effects are associated with amantadine?
Confusion, hallucinations, anticholinergic symptoms, and livedo reticularis (mottled skin).
43
New cards
[Benztropine & anticholinergics] What is benztropine's drug class and Parkinson role?
A centrally acting anticholinergic that mainly reduces tremor and sometimes rigidity, with little benefit for bradykinesia.
44
New cards
[Benztropine & anticholinergics] Why are anticholinergics such as benztropine usually avoided in older adults with Parkinson disease?
They can cause confusion, hallucinations, urinary retention, constipation, and other cognitive adverse effects.
45
New cards
[Parkinson nursing scenarios] A Parkinson patient reports compulsive gambling after starting pramipexole. What should the nurse do?
Recognize a possible dopamine-agonist impulse-control adverse effect and promptly notify the prescriber.
46
New cards
[Parkinson nursing scenarios] A Parkinson patient becomes dizzy when standing after levodopa. What is the nursing response?
Assess orthostatic blood pressure, implement fall precautions, and communicate persistent symptoms.
47
New cards
[Parkinson nursing scenarios] A Parkinson patient says medication suddenly stops working before the next dose. What should be documented?
Timing, duration, severity, and relationship of "off" episodes to levodopa doses and meals.
48
New cards
[Alzheimer disease] What early brain area affected by Alzheimer disease helps explain short-term memory loss?
The hippocampus; cortical involvement later affects language, judgment, and daily functioning.
49
New cards
[Alzheimer disease] What are the two main Alzheimer dementia medication classes in these slides?
Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and the NMDA antagonist memantine.
50
New cards
[Alzheimer disease] What is the therapeutic goal of cholinesterase inhibitors in Alzheimer disease?
Temporarily improve or slow decline in cognition/function; they do not cure the disease or stop progression.
51
New cards
[Donepezil] What is the mechanism of action of donepezil?
Reversible inhibition of acetylcholinesterase, increasing available acetylcholine.
52
New cards
[Donepezil] What is donepezil's brand name and general indication?
Aricept; indicated for mild, moderate, or severe Alzheimer dementia.
53
New cards
[Donepezil] What adverse effects are especially important with donepezil?
Nausea/diarrhea, bradycardia, syncope, falls, and possible weight loss.
54
New cards
[Rivastigmine] What drug class does rivastigmine belong to?
Cholinesterase inhibitor; available as oral and transdermal formulations for dementia management.
55
New cards
[Rivastigmine] What are key adverse effects of rivastigmine?
Nausea, vomiting, diarrhea, anorexia, weight loss, and possible bradycardia/syncope.
56
New cards
[Galantamine] What is galantamine's drug class?
Reversible cholinesterase inhibitor used for mild to moderate Alzheimer dementia.
57
New cards
[Cholinesterase inhibitors] What adverse effects are shared by donepezil, rivastigmine, and galantamine?
Cholinergic GI symptoms, decreased appetite/weight loss, bradycardia, and fall/syncope risk.
58
New cards
[Cholinesterase inhibitors] Which preexisting conditions warrant added caution with cholinesterase inhibitors?
Bradyarrhythmias, peptic ulcer disease, urinary obstruction, and reactive airway disease.
59
New cards
[Cholinesterase inhibitors] Which drugs may counteract the effects of cholinesterase inhibitors?
Anticholinergics, including some first-generation antihistamines, tricyclic antidepressants, and older antipsychotics.
60
New cards
[Memantine] What is memantine's mechanism of action?
NMDA (N-methyl-D-aspartate) receptor antagonism, reducing pathologic glutamate signaling.
61
New cards
[Memantine] For what severity of Alzheimer disease is memantine indicated in the lecture?
Moderate to severe Alzheimer dementia.
62
New cards
[Memantine] What are common adverse effects of memantine?
Dizziness, headache, confusion, and constipation.
63
New cards
[Alzheimer nursing scenarios] An older adult taking donepezil faints and has a pulse of 46/min. What concern takes priority?
Possible medication-associated bradycardia and syncope; assess hemodynamic stability and notify the prescriber.
64
New cards
[Alzheimer nursing scenarios] Which Alzheimer drug would you associate with NMDA antagonism rather than increasing acetylcholine?
Memantine (Namenda).
65
New cards
[Multiple sclerosis] What type of disease is multiple sclerosis?
An immune-mediated demyelinating CNS disorder that can cause relapses and progressive neurologic disability.
66
New cards
[Multiple sclerosis] What is the main purpose of MS disease-modifying therapies?
Reduce relapses and lesion activity and delay disability progression; they do not cure MS.
67
New cards
[Multiple sclerosis] Which MS course generally responds best to disease-modifying medications?
Relapsing-remitting multiple sclerosis.
68
New cards
[Multiple sclerosis] How are significant acute MS relapses often treated?
A short course of high-dose glucocorticoids, commonly IV methylprednisolone, to hasten recovery.
69
New cards
[Interferon beta] What are major adverse effects of interferon beta for MS?
Flu-like symptoms, injection-site reactions, liver injury, bone-marrow suppression, and mood changes including depression.
70
New cards
[Interferon beta] What tests/symptoms are important while monitoring interferon beta?
CBC, liver enzymes, and new or worsening depression or suicidal thoughts.
71
New cards
[Dimethyl fumarate] What is dimethyl fumarate's class and use?
Oral immunomodulator used for relapsing forms of MS.
72
New cards
[Dimethyl fumarate] What are important risks of dimethyl fumarate?
Flushing, GI upset, and lymphopenia; monitor blood counts and infection risk.
73
New cards
[Glatiramer acetate] What is glatiramer acetate's class and action?
Immunomodulator that shifts immune reactivity away from myelin; used for relapsing MS.
74
New cards
[Glatiramer acetate] What is a typical adverse effect of glatiramer acetate?
Injection-site reactions; unlike interferon beta it generally does not cause flu-like symptoms or major liver toxicity.
75
New cards
[Natalizumab] What severe neurologic infection is associated with natalizumab?
Progressive multifocal leukoencephalopathy (PML), a serious JC-virus-associated brain infection.
76
New cards
[Natalizumab] What symptoms require urgent reporting in a patient taking natalizumab?
New or worsening weakness, visual/language changes, cognitive changes, or other unusual neurologic deficits that could suggest PML.
77
New cards
[Fingolimod] What is fingolimod's mechanism of action?
Sphingosine-1-phosphate receptor modulation that sequesters lymphocytes and limits their entry into the CNS.
78
New cards
[Fingolimod] Why is the first dose of fingolimod associated with cardiac monitoring?
It can cause clinically significant bradycardia or conduction slowing.
79
New cards
[Fingolimod] What other serious adverse effects should be monitored with fingolimod?
Macular edema, infection, liver injury, and impaired pulmonary function.
80
New cards
[Teriflunomide] What is teriflunomide's mechanism of action?
Inhibits pyrimidine synthesis, decreasing proliferation of activated T and B lymphocytes.
81
New cards
[Teriflunomide] What key contraindications are associated with teriflunomide?
Pregnancy and significant liver disease because of fetal harm and hepatotoxicity risks.
82
New cards
[Mitoxantrone] What is mitoxantrone's major nursing concern in MS treatment?
Cardiotoxicity and myelosuppression; it is a higher-toxicity immunosuppressant.
83
New cards
[MS spasticity] Which MS medications are commonly used to reduce spasticity?
Baclofen and tizanidine; diazepam or botulinum toxin may be used in selected cases.
84
New cards
[Dalfampridine] What is dalfampridine used for in MS?
Improve walking by blocking potassium channels in demyelinated axons.
85
New cards
[Dalfampridine] What major adverse effect must be considered with dalfampridine?
Seizures; seizure history and renal function are important safety considerations.
86
New cards
[MS neuropathic pain] Which medications may be used for neuropathic pain in MS?
Gabapentin, carbamazepine, oxcarbazepine, or selected antidepressants, rather than relying only on standard analgesics.
87
New cards
[Seizure medications] What is the primary goal of long-term antiseizure therapy?
Prevent seizures with the fewest possible adverse effects while supporting adherence and quality of life.
88
New cards
[Seizure medications] What are the two broad groups of antiseizure medications described in the slides?
Traditional agents (e.g., phenytoin, carbamazepine, valproate, ethosuximide, phenobarbital) and newer agents (e.g., lamotrigine, levetiracetam, oxcarbazepine).
89
New cards
[Phenytoin] What is phenytoin's drug class and mechanism?
Traditional antiseizure drug that limits repetitive neuronal firing by blocking voltage-gated sodium channels.
90
New cards
[Phenytoin] What is the typical total phenytoin therapeutic serum concentration?
10–20 mcg/mL; interpret with albumin level, free phenytoin if indicated, symptoms, and the laboratory's reference range.
91
New cards
[Phenytoin] Which seizures is phenytoin used to manage?
Focal-onset and generalized tonic-clonic seizures; not absence seizures.
92
New cards
[Phenytoin] What neurologic signs suggest phenytoin toxicity?
Nystagmus, ataxia, slurred speech, diplopia, sedation, and impaired coordination.
93
New cards
[Phenytoin] What oral adverse effect is characteristic of phenytoin?
Gingival hyperplasia; emphasize brushing, flossing, and routine dental care.
94
New cards
[Phenytoin] What important interaction may occur between phenytoin and hormonal contraception?
Enzyme induction can reduce contraceptive effectiveness; review backup or alternative methods with the prescriber.
95
New cards
[Phenytoin] Why is phenytoin dosing and concentration monitoring especially important?
It has nonlinear/saturable metabolism and a narrow therapeutic range; small dose changes may raise levels disproportionately.
96
New cards
[Fosphenytoin] What is fosphenytoin used for?
Injectable phenytoin prodrug used when rapid parenteral antiseizure treatment is needed, including status epilepticus after initial stabilization.
97
New cards
[Fosphenytoin] What is an important monitoring priority during IV fosphenytoin?
ECG, blood pressure, and respiratory status because rapid administration can cause cardiac and hemodynamic adverse effects.
98
New cards
[Carbamazepine] What is carbamazepine's mechanism and common use?
Sodium-channel blockade; used for focal-onset seizures and also trigeminal neuralgia and some bipolar presentations.
99
New cards
[Carbamazepine] What serious blood abnormality is associated with carbamazepine?
Aplastic anemia or agranulocytosis; monitor CBC and report fever, sore throat, bruising, or infection.
100
New cards
[Carbamazepine] What dangerous cutaneous reaction can occur with carbamazepine?
Stevens-Johnson syndrome/toxic epidermal necrolysis; report blistering rash or mucosal lesions urgently.
Load more